Advice

Discontinuation of docetaxel (Taxotere)

The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.

Medicine details

Medicine name:
docetaxel (Taxotere)
SMC ID:
369/07
Indication:
Unresectable locally advanced squamous cell carcinoma of the head and neck
Pharmaceutical company
Sanofi-Aventis
BNF chapter
Malignant disease and immunosuppression
Submission type
Full
Status
Withdrawn
Date advice published:
07 May 2007
Archive advice

The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.